Pharmacological Treatment of Insomnia in Palliative Care
Status:
Completed
Trial end date:
2021-07-13
Target enrollment:
Participant gender:
Summary
Sleep disturbance is frequent in patients with advanced cancer and decreases the tolerability
of other symptoms and impairs quality of life. A detailed description of sleep disturbance
and its association with other symptoms, and intervention studies on sleep medications are
scarce in patients with advanced cancer. A well-designed randomized controlled trial is
needed to determine the short time effectiveness of zopiclone on sleep quality, one of the
currently available therapies of insomnia, and further to contribute to the clinical
management of insomnia in patients with advanced cancer.